TrialBMC cancer2023

Efficacy and safety of fluzoparib combined with anlotinib in extensive stage small cell lung cancer after first-line platinum-based chemotherapy: a multi-center, single-arm prospective phase II clinical study (STAMP study).

Deyu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.